Tuesday, March 29, 2022

Recce Pharmaceuticals granted A$3 million boost for infectious disease R&D.


 



Recce Pharmaceuticals granted A$3 million boost for infectious disease R&D.
Visit: https://infectious.pencis.com/
#health #covid #medicine #medical #doctor #virus #coronavirus #science #healthcare #cancer #diabetes #doctors #hospital #corona #healthylifestyle #india #prevention #cure #love #life #healthy #treatment #vegan #nutrition #awareness #mbbs #surgery #pandemicVisit: https://infectious.pencis.com/
#health #covid #medicine #medical #doctor #virus #coronavirus #science #healthcare #cancer #diabetes #doctors #hospital #corona #healthylifestyle #india #prevention #cure #love #life #healthy #treatment #vegan #nutrition #awareness #mbbs #surgery #pandemic
-

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Biogenic Copper-Based Nanoparticles: Emerging Antimicrobial Agents Against Pathogenic Microorganisms | Nanomedicine & Infection Control #researchawards

Introduction Biogenic copper-based nanoparticles (CuNPs) have emerged as promising antimicrobial agents due to their potent activity and en...